1252905-76-2

Upstream product

• 1228430-42-9 N-[(1S)-1-({[(1,1-dimethylethyl)(diphenyl)silyl]oxy}methyl)-3-buten-1-yl]-4-methyl-benzenesulfonamide 
• 1228430-43-0 N-[(1S)-1-({[(1,1-dimethylethyl)(diphenyl)silyl]oxy}methyl)-3-buten-1-yl]-4-methyl-N-2-propen-1-ylbenzenesulfonamide 
• 417726-36-4 (S)-1-(tert-butoxycarbonyl)-1,2,3,6-tetrahydropyridine-2-carboxylic acid 
• 1228430-37-2 (S)-1-tert-butyl 2-methyl 2,3-dihydropyridine-1,2(6H)-dicarboxylate 
• 1228188-17-7 6-methyl-3-(2-pyrimidinyl)-2-pyridinecarbonitrile 
• 1228188-16-6 3-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-6-methylpyridine-2-carbonitrile 
• 717843-48-6 3-bromo-6-methylpyridine-2-carbonitrile 
• 1620-75-3 2-Cyano-6-methylpyridine 
• 1228188-18-8 6-methyl-3-(pyrimidin-2-yl)pyridine-2-carboxylic acid 
• 1228430-55-4 (1R,4S,6R)-4-({[(1,1-dimethylethyl)(diphenyl)silyl]oxy}methyl)-3-azabicyclo[4.1.0]heptane 

Relevant academic research and scientific papers

AZABICYCLO [4.1.0] HEPT - 4 - YL DERIVATIVES AS HUMAN OREXIN RECEPTOR ANTAGONISTS

This invention relates to azabicyclo[4.1.0]hept-4-yl derivatives and their use as pharmaceuticals.

NOVEL COMPOUNDS

Disclosed are N-{[(1R,4S,6R)-3-(2-pyridinylcarbonyl)-3-azabicyclo[4.1.0]hept-4-yl]methyl}-2-heteroarylamine derivatives and their use as pharmaceuticals.

3 -AZABICYCLO [4.1.0] HEPTANES USED AS OREXIN ANTAGONISTS

This invention relates to 3-azabicyclo[4.1.0] heptane derivatives (I) and their use as orexin receptor antagonists.